Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy

PURPOSE: The purpose of this study was to define the role of cyclooxygenase-2 inhibitors (COX-2i) in reducing hepatic fibrosis in pediatric patients with chronic liver disease. MATERIALS AND METHODS: From September 2009 to September 2010, patients over 2 years old who visited our outpatient clinic f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hye Kyung, Chang, Eun Young, Ryu, Seonae, Han, Seok Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951465/
https://www.ncbi.nlm.nih.gov/pubmed/27189282
http://dx.doi.org/10.3349/ymj.2016.57.4.893

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951465/
https://www.ncbi.nlm.nih.gov/pubmed/27189282
http://dx.doi.org/10.3349/ymj.2016.57.4.893

Ejemplares similares